Baird Medical Investment Holdings Limited (BDMD) vs Context Therapeutics Inc. (CNTX)
A side-by-side comparison of Baird Medical Investment Holdings Limited and Context Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDMD
Baird Medical Investment Holdings Limited
$0.73HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CNTX
Context Therapeutics Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — BDMD vs CNTX
growth of $100 · dividends reinvested · last 5yBDMD -92.3% (-40.1%/yr)CNTX -89.6% (-36.4%/yr)CNTX compounded faster over this window
BDMD CNTX
BDMD vs CNTX: by the numbers
- •CNTX is the larger company ($31M vs $31M market cap).
- •Both run net losses; CNTX's is the smaller (0.00% vs -121.04% net margin).
Metrics side by side
Valuation
| Metric | BDMD | CNTX |
|---|---|---|
| Forward P/E | 9.13 | N/A |
| P/B ratio | 0.89 | 0.82 |
Profitability
| Metric | BDMD | CNTX |
|---|---|---|
| Gross margin | 83.79% | 0.00% |
| Operating margin | -113.31% | 0.00% |
| Net margin | -121.04% | 0.00% |
| ROE | -86.96% | -120.40% |
| ROIC | -50.66% | -126.84% |
Growth (annualized)
| Metric | BDMD | CNTX |
|---|---|---|
| Revenue CAGR (5Y) | 4.46% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.